3 terminated, 1 completed. 3 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 2, Completed 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Terminated 1 |
Follow SerpinPC: new trials by email Literature Review of SerpinPC trials Research Report on SerpinPC
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Long-term Safety and Efficacy of SerpinPC in Subjects with Hemophilia Who Completed a Sponsored SerpinPC Clinical Trial SerpinPC - Hemophilia a, Hemophilia B | Phase 3 | Terminated | ApcinteX Ltd | 15 | 2024-07-11 | 2025-02-10 |
| A Study of SerpinPC in Participants with Hemophilia B (HemB) with Inhibitors SerpinPC - Hemophilia B with Inhibitor, Hemophilia B | Phase 2 | Terminated | ApcinteX Ltd | 3 | 2023-07-28 | 2025-03-11 |
| The Efficacy and Safety of SerpinPC in Participants with Severe Hemophilia a or Moderately Severe to Severe Hemophilia B SerpinPC - Hemophilia a, Hemophilia B | Phase 2 | Terminated | ApcinteX Ltd | 60 | 2023-07-06 | 2025-03-11 |
| The Safety and Tolerability of SerpinPC in Healthy Men and in Men with Severe Blood Disorders (haemophilia a and B) SerpinPC, Placebo - Hemophilia a, Hemophilia B | Phase 1 / Phase 2 | Completed | ApcinteX Ltd | 39 | 2019-08-14 | 2025-02-06 |
Hemophilia A (4) · Hemophilia B (4)
ApcinteX Ltd (4)
United Kingdom (3) · Armenia (2) · Australia (2) · France (2) · Georgia (2) · Germany (2) · India (2) · Italy (2) · Moldova (2) · Spain (2) · Taiwan (2) · Turkey (Türkiye) (2) · United States (2) · Belgium (1) · Canada (1)
2023 (1)